Medifast Revenues up 26%
Medifast (NYSE: MED) reported revenue of $105.4 million for the fiscal year ended December 31, 2008, an increase of 26% from $83.8 million for the fiscal year ended December 31, 2007. Fourth quarter revenues increased 29% to 25.5 million from $19.8 million in the fourth quarter of 2007.
The company reported net income of $5.4 million for fiscal 2008, versus $3.8 million in 2007.
Medallion Financial Q4 Income Up 76%
Medallion Financial Corp (Nasdaq: TAXI), a specialty finance company, reported that its earnings, or net increase in net assets resulting from operations was $2,832,000 in the 2008 fourth quarter, compared to $3,782,000 in the 2007 fourth quarter.
For the 2008 full year, net increase in net assets resulting from operations decreased 1% to $15,248,000 from $15,436,000 in 2007. Net investment income after taxes was $4,443,000 in the 2008 fourth quarter, up 76% from $2,520,000 in the 2007 fourth quarter. For the 2008 full year, net investment income after taxes increased to $15,090,000 up from $5,298,000 in 2007.
Gramercy Capital Revenues Up $287 million
Gramercy Capital Corp (NYSE: GKK) reported total revenues of $165.4 million during the fourth quarter, an increase of $80.5 million from the $84.9 million generated during the same quarter of the prior year. Total revenues were $602.1 million for 2008, an increase of $286.7 million from the $315.4 million generated during the prior year.
As of December 31, 2008, approximately 51.3% of the company’s assets were comprised of commercial property, 28.3% of debt investments, 11.1% of commercial mortgage real estate securities and 9.3% of other assets.
Raven Industries Sales Up 20%
Raven Industries (Nasdaq: RAVN) has reported that its fiscal 2009 annual sales grew 20 percent to $279.9 million, compared with $234 million in fiscal 2008. Net income increased by 11 percent to $30.8 million from $27.8 million.
NxStage Reports Record Revenue
NxStage Medical (Nasdaq: NXTM) reported that its net revenue for the fourth quarter of 2008 increased 19 percent to $35.7 million compared with revenue of $29.9 million for the fourth quarter of 2007. For 2008, revenue increased 115 percent to $128.8 million compared with revenue of $60.0 million in 2007.
Caliper Life Sciences Reports Loss
Caliper Life Sciences (Nasdaq: CALP) reported that its fourth quarter revenues were $36.7 million, a decline of 8.8%, from $40.3 million in the same period in 2007. Caliper's GAAP net loss for the fourth quarter was $46.3 million compared to a net loss of $5.7 million in the same quarter of 2007.
On a full year basis, 2008 revenues were $134.1 million, a decline of 4.7%, compared to $140.7 million in 2007. Net loss for the full year was $68.3 million compared to a net loss of $24.1 million in 2007.
